Vostrikova T.Yu.

Latest

• Infectious endocarditis caused by Cutibacterium avidum in a patient with endocardial pacemaker and multiple drug hypersensitivity reactions: a clinical case

  Clinical Microbiology and Antimicrobial Chemotherapy. 2024; 26(2):208-214

• Rapid syndromic approach to diagnosis of bacteremia – results of the first experience

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(3):304-310

• Carriage of K. pneumoniae and molecular structure of produced carbapenemases in infants with congenital heart defects

  Clinical Microbiology and Antimicrobial Chemotherapy. 2023; 25(2):202-210

• Carriage of antibiotic-resistant bacteria and etiology of postoperative infectious complications in infants with congenital heart defects

  Clinical Microbiology and Antimicrobial Chemotherapy. 2022; 24(2):139-146

• Antimicrobial resistance, carbapenemase production, and genotypes of nosocomial Acinetobacter spp. isolates in Russia: results of multicenter epidemiological study ”MARATHON 2015–2016”

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(2):171-180

• Antimicrobial resistance, carbapenemase production, and genotypes of nosocomial Pseudomonas aeruginosa isolates in Russia: results of multicenter epidemiological study “MARATHON 2015–2016”

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(2):160-170

• Antimicrobial resistance of nosocomial Enterobacterales isolates in Russia: results of multicenter epidemiological study “MARATHON 2015–2016”

  Clinical Microbiology and Antimicrobial Chemotherapy. 2019; 21(2):147-159

• Accelerated Techniques of Pathogen Identification from Positive Blood Cultures by MALDI-TOF Mass Spectrometry

  Clinical Microbiology and Antimicrobial Chemotherapy. 2016; 18(4):296-307

• Fungal Infections Surveillance in Intensive Care Units

  Clinical Microbiology and Antimicrobial Chemotherapy. 2009; 11(1):22-30

• Recommendations on the Optimization of Antimicrobial Chemotherapy of Nosocomial Infections Caused by GramdNegative Bacteria in Intensive Care Units (Guidelines for clinicians)

  Clinical Microbiology and Antimicrobial Chemotherapy. 2002; 4(4):379-390